These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Progress and promise for the MDMA drug development program. Feduccia AA; Holland J; Mithoefer MC Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674 [TBL] [Abstract][Full Text] [Related]
7. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. Bouso JC; Doblin R; Farré M; Alcázar MA; Gómez-Jarabo G J Psychoactive Drugs; 2008 Sep; 40(3):225-36. PubMed ID: 19004414 [TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD. Marseille E; Kahn JG; Yazar-Klosinski B; Doblin R PLoS One; 2020; 15(10):e0239997. PubMed ID: 33052965 [TBL] [Abstract][Full Text] [Related]
9. The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD. Brewerton TD; Lafrance A; Mithoefer MC Med Hypotheses; 2021 Jan; 146():110367. PubMed ID: 33203569 [TBL] [Abstract][Full Text] [Related]
10. The Emerging Field of Psychedelic Psychotherapy. Barber GS; Aaronson ST Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571 [TBL] [Abstract][Full Text] [Related]
12. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis. Smith KW; Sicignano DJ; Hernandez AV; White CM J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874 [TBL] [Abstract][Full Text] [Related]
13. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331 [TBL] [Abstract][Full Text] [Related]
14. Why MDMA therapy for alcohol use disorder? And why now? Sessa B Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911 [TBL] [Abstract][Full Text] [Related]
15. Research on psychedelics moves into the mainstream. Morris K Lancet; 2008 May; 371(9623):1491-2. PubMed ID: 18459186 [No Abstract] [Full Text] [Related]
16. Will MDMA-assisted psychotherapy become a breakthrough in treatment-resistant post-traumatic stress disorder? A critical narrative review. Szafoni S; Więckiewicz G; Pudlo R; Gorczyca P; Piegza M Psychiatr Pol; 2022 Aug; 56(4):823-836. PubMed ID: 37074831 [TBL] [Abstract][Full Text] [Related]
17. Review of potential psychedelic treatments for PTSD. Henner RL; Keshavan MS; Hill KP J Neurol Sci; 2022 Aug; 439():120302. PubMed ID: 35700643 [TBL] [Abstract][Full Text] [Related]
18. MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms? Feduccia AA; Mithoefer MC Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):221-228. PubMed ID: 29524515 [TBL] [Abstract][Full Text] [Related]
19. Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder. Ponte L; Jerome L; Hamilton S; Mithoefer MC; Yazar-Klosinski BB; Vermetten E; Feduccia AA J Trauma Stress; 2021 Aug; 34(4):851-863. PubMed ID: 34114250 [TBL] [Abstract][Full Text] [Related]
20. MDMA and PTSD treatment: "PTSD: From novel pathophysiology to innovative therapeutics". Sessa B Neurosci Lett; 2017 May; 649():176-180. PubMed ID: 27394687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]